globalnews.ca
35%
966
Here’s what we know so far about Trump’s experimental coronavirus treatment
Donald Trump has been called one of the most promising approaches to preventing serious illness from a COVID-19 infection.Its maker, Regeneron Pharmaceuticals Inc., said the company agreed to supply a single dose, given through an IV, for Trump at the request of his physician under “compassionate use” provisions, when an experimental medicine is provided on a case-by-case emergency basis, while studies of it continue.Notably, before heading to the hospital the president was treated with the highest dose of Regeneron’s monoclonal antibody cocktail. This experimental therapeutic hasn't been authorized or approved by the FDA.